Jundishapur Journal of Natural Pharmaceutical Products

Published by: Kowsar

Nasal Drug Delivery in Traditional Persian Medicine

Mohammad Mehdi Zarshenas 1 , 2 , Arman Zargaran 3 , 4 , * , Johannes Müller 5 and Abdolali Mohagheghzadeh 2 , 3
Authors Information
1 Student Research Committee, Shiraz University of Medical Sciences, Shiraz, IR Iran
2 Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, IR Iran
3 Department of Traditional Pharmacy, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, IR Iran
4 Research Office for the History of Persian Medicine, Shiraz University of Medical Sciences, Shiraz, IR Iran
5 University of Marburg, Institute for the History of Pharmacy, Germany
Article information
  • Jundishapur Journal of Natural Pharmaceutical Products: August 17, 2013, 8 (3); 144-148
  • Published Online: July 16, 2013
  • Article Type: Rapid Communication
  • Received: December 27, 2012
  • Revised: March 13, 2013
  • Accepted: April 15, 2013
  • DOI: 10.17795/jjnpp-9990

To Cite: Zarshenas M M, Zargaran A, Müller J, Mohagheghzadeh A. Nasal Drug Delivery in Traditional Persian Medicine, Jundishapur J Nat Pharm Prod. 2013 ; 8(3):144-148. doi: 10.17795/jjnpp-9990.

Abstract
Copyright © 2013, School of Pharmacy, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Borchardt JK. The Beginnings of Drug Therapy: Ancient Mesopotamian Medicine. Drug News Perspect. 2002; 15(3): 187-192[DOI][PubMed]
  • 2. Kasthuri KT, Radha R, Jayshree N, Austin A, Thirugnanasambantham P. Standardization and In Vitro Anti Inflammatory Studies of A Poly Herbal Oil Formulation–Megni. Res J Pharm Technol. 2010; 3(3): 792-4
  • 3. Buerki RA, Higby GJ. Encyclopedia of Pharmaceutical Technology. 2006; : 948-74
  • 4. Levy G. Effect of Dosage Form on Drug Absorption a Frequent Variable in Clinical Pharmacology. Arch Int Pharmacodyn Ther. 1964; 152: 59-68[PubMed]
  • 5. Khaleghi Ghadiri M, Gorji A. Natural remedies for impotence in medieval Persia. Int J Impot Res. 2004; 16(1): 80-3[DOI][PubMed]
  • 6. Zargaran A, Zarshenas MM, Hosseinkhani A, Mehdizadeh A. Jawarish, a Persian traditional gastrointestinal dosage form. Pharm Hist (Lond). 2012; 42(2): 24-5[PubMed]
  • 7. Zargaran A, Zarshenas MM, Mehdizadeh A, Mohagheghzadeh A. Oxymel in medieval Persia. Pharm Hist (Lond). 2012; 42(1): 11-3[PubMed]
  • 8. Ramezany F, Ardakani MR. Ali ibn Hosein Ansari (1330-1404): a Persian pharmacist and his pharmacopoeia, Ekhtiyarat i Badi i. J Med Biogr. 2011; 19(2): 80-3[DOI][PubMed]
  • 9. Levy M. Medical Formulary or Aqrabadhin of Al-Kindi. 1999;
  • 10. Dhuria SV, Hanson LR, Frey WH, 2nd. Intranasal delivery to the central nervous system: mechanisms and experimental considerations. J Pharm Sci. 2010; 99(4): 1654-73[DOI][PubMed]
  • 11. Alsarra IA, Hamed AY, Alanazi FK, El Maghraby GM. Drug Delivery to the Central Nervous System. 2010; : 175-203[DOI]
  • 12. Ugwoke MI, Verbeke N, Kinget R. The biopharmaceutical aspects of nasal mucoadhesive drug delivery. J Pharm Pharmacol. 2001; 53(1): 3-21[DOI][PubMed]
  • 13. Putheti RR, Patil MC, Obire O. Nasal Drug delivery in Pharmaceutical and biotechnology: present and future. Sci Technol. 2009; 4(3): 1-12
  • 14. Heravi MG. [Qarabadin-e-salehi]. 1765;
  • 15. Avicenna .. [Canon of Medicine]. 1988;
  • 16. Arzani A. [Qarabadin Ghaderi]. 1861;
  • 17. Shirazi SA. [Qarabadin-e-Kabir]. 1855;
  • 18. Azam Khan Cheshti H. [Qarabadin-Azam]. 1809;
  • 19. Shirazi M. [Makhzan ol Advieh]. 1992;
  • 20. [Program Book of Ph.D Degree in Traditional Persian Pharmacy]. 2007;
  • 21. Soltani A. [Dictionary of Medicinal Plants]. 2004;
  • 22. Amin G. [Popular Medicinal Plants of Iran]. 2005;
  • 23. Dymook W, Warden CJH, Hooper D. Pharmacographica Indica. 1893;
  • 24. Baraniuk JN, Merck SJ. Neuroregulation of human nasal mucosa. Ann N Y Acad Sci. 2009; 1170: 604-9[DOI][PubMed]
  • 25. Cooke B, Ernst E. Aromatherapy: a systematic review. Br J Gen Pract. 2000; 50(455): 493-6[PubMed]
  • 26. De Ascentiis A, Bettini R, Caponetti G, Catellani PL, Peracchia MT, Santi P, et al. Delivery of nasal powders of beta-cyclodextrin by insufflation. Pharm Res. 1996; 13(5): 734-8[DOI][PubMed]
  • 27. Vardakou I, Pistos C, Spiliopoulou C. Drugs for youth via Internet and the example of mephedrone. Toxicol Lett. 2011; 201(3): 191-5[DOI][PubMed]
  • 28. Hill S, Sikand H, Lee J. A case report of seizure induced by bupropion nasal insufflation. Prim Care Companion J Clin Psychiatry. 2007; 9(1): 67-9[DOI][PubMed]
  • 29. Amruthesh S. Dentistry and Ayurveda - IV: classification and management of common oral diseases. Indian J Dent Res. 2008; 19(1): 52-61[DOI][PubMed]
  • 30. Bhatted S, Shukla VD, Thakar A, Bhatt NN. A study on Vasantika Vamana (therapeutic emesis in spring season) - A preventive measure for diseases of Kapha origin. Ayu. 2011; 32(2): 181-6[DOI][PubMed]
  • 31. Jadhav KR, Gambhire MN, Shaikh IM, Kadam VJ, Pisal SS. Nasal drug delivery system-factors affecting and applications. Current drug therapy. 2007; 2(1): 27-38
  • 32. Illum L. Nasal drug delivery - recent developments and future prospects. J Control Release. 2012; 161(2): 254-63[DOI][PubMed]
  • 33. Landis MS, Boyden T, Pegg S. Nasal-to-CNS drug delivery: where are we now and where are we heading? An industrial perspective. Ther Deliv. 2012; 3(2): 195-208[DOI][PubMed]
  • 34. Illum L. Nasal drug delivery--possibilities, problems and solutions. J Control Release. 2003; 87(1-3): 187-98[DOI][PubMed]
  • 35. Arora P, Sharma S, Garg S. Permeability issues in nasal drug delivery. Drug Discov Today. 2002; 7(18): 967-75[DOI][PubMed]
  • 36. Bertram U, Bodmeier R. In situ gelling, bioadhesive nasal inserts for extended drug delivery: in vitro characterization of a new nasal dosage form. Eur J Pharm Sci. 2006; 27(1): 62-71[DOI][PubMed]
  • 37. Schipper NG, Verhoef JC, Merkus FW. The nasal mucociliary clearance: relevance to nasal drug delivery. Pharm Res. 1991; 8(7): 807-14[DOI][PubMed]
  • 38. Bhat RB, Jacobs TV. Traditional herbal medicine in Transkei. J Ethnopharmacol. 1995; 48(1): 7-12[DOI][PubMed]
  • 39. Chui SH, Shek SL, Fong MY, Szeto YT, Chan K. A panel study to evaluate quality of life assessments in patients suffering from allergic rhinitis after treatment with a Chinese herbal nasal drop. Phytother Res. 2010; 24(4): 609-13[DOI][PubMed]
  • 40. Chan AS, Cheung MC, Sze SL, Leung WW, Shi D. An herbal nasal drop enhanced frontal and anterior cingulate cortex activity. Evid Based Complement Alternat Med. 2011; 2011: 543648[DOI][PubMed]
  • 41. Bhise SB, Yadav AV, Avachat AM, Malayandi R. Bioavailability of intranasal drug delivery system. Asian J Pharm. 2008; 2(4): 201[DOI]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments